ReviewCurrent obesity reports2026
The Gut-brain-adipose Axis in Ultra-processed Food and Obesity: A Mechanistic Synthesis and Its Implications for Food Classification.
Review in Current obesity reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- When Ultra-Processed Foods are Eaten: The Missing Dimension in Exposure Measurement for Obesity Research.Current obesity reports · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewConsumption of ultra-processed food (UPF) tracks closely with obesity across populations, and the Nova classification has become the dominant tool for capturing that exposure. Why UPF promotes weight gain is a separate question, and the biological answer has accumulated in fragments. I draw those strands together and ask whether three mechanisms usually studied in isolation: gut microbial disruption, hypothalamic inflammation, and adipose tissue dysfunction, are better understood as one connected system, and what that would mean for how UPF is classified. RECENT
findingsThree experimental literatures have converged on a shared pathway. Dietary emulsifiers and non-sugar sweeteners alter microbial composition and weaken the intestinal barrier, raising circulating lipopolysaccharide. In animal models this signal reaches the hypothalamus, where it activates inflammatory pathways, recruits glia, and blunts the leptin response that normally limits intake; though whether the same sequence operates in humans remains unestablished. Visceral fat that expands under this regime secretes its own inflammatory load, which feeds back onto both the gut and the brain. A 2025 UK Biobank analysis added a human imaging dimension, reporting structural differences in feeding-related brain regions that scaled with UPF intake and were only partly explained by adiposity. The evidence coheres best when the three arms are read as a single self-reinforcing loop in which each influences the others. Within that frame, the limitation of the Nova classification becomes specific and tractable: Group 4 mixes products that engage the loop strongly with products that barely touch it. This review sets out where the mechanistic evidence is firm, where it remains thin, and how an attribute-aware refinement of Group 4 might be tested.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.